The Hiring Decision You're About to Make Will Be Made by the Wrong Person
Why letting your most technical cofounder lead early hiring quietly wrecks commercialization timelines at deep tech startups.
W. Osei Lab to Launch
Blog
From Bench to Business
W. Osei All Posts
The Regulatory Pathway Your CTO Mapped Out Is Based on the Wrong Device Classification
Misclassifying your medical device early costs far more than a filing fee. Here's how deep tech founders get device classification wrong and what to fix.
W. OseiThe Patent License Your Startup Is Building On Was Never Actually Validated
Most deep tech founders assume a university patent license equals protected IP. It rarely does. Here's what you're actually signing and why it matters.
W. OseiThe Insurance Coverage Your Hospital Pilot Requires Will Blindside Your Budget and Your Timeline
Hospital pilots demand insurance coverage most deep tech startups don't have and can't get quickly. Here's what's actually required and how to plan for it.
W. OseiThe Quality Management System Your Contract Manufacturer Insisted On Will Bury You in Paper and Miss Every Real Problem
Most deep tech startups implement QMS requirements from their contract manufacturer without realizing the system is designed for their vendor's audits, not your product quality.
W. OseiThe FDA Pre-Submission Meeting You're Skipping Will Cost You Eighteen Months
Skipping an FDA pre-submission meeting feels like saving time. It usually costs 18+ months. Here's what founders get wrong and how to fix it.
W. OseiThe Vendor Contract Your CRO Sent You Was Written to Protect Them, Not Your Data
Most deep tech founders sign CRO contracts without reading the IP and data ownership clauses. Here's what you're actually giving away.
W. OseiThe Clinical Trial Site You Picked Based on Relationships Will Blow Your Timeline
Choosing a clinical trial site because you know the PI is one of the most common and expensive mistakes early-stage medtech and biotech founders make.
W. OseiThe Reimbursement Code Your Medtech Startup Is Counting On Doesn't Exist Yet
Most medtech founders assume a CPT or ICD code will be waiting when they're ready to sell. Here's why that assumption will wreck your commercial timeline.
W. OseiThe Equity Split You Agreed to on a Napkin Will End Your Company in Year Three
That informal equity split you shook hands on feels fine now. Here's exactly why it becomes a catastrophic problem the moment real money shows up.
W. OseiThe Reference Customer You're About to Name in Your Pitch Deck Is Going to Call You a Liar
Before you put a customer logo in your pitch deck, understand exactly what that relationship actually means and what they'll say when investors call.
W. OseiThe Conflict of Interest Your Scientific Advisor Never Disclosed Will Torpedo Your Deal
Your scientific advisor's undisclosed competing interests can blow up a funding round or partnership deal. Here's what to find before it's too late.
W. OseiThe Investor Update Email You've Been Sending Is Actively Hurting Your Fundraise
Your monthly investor update feels like good practice, but the way most founders write it quietly closes doors before the next round even opens.
W. OseiThe Cap Table Your Seed Investor Just Signed Will Haunt Every Future Round
The cap table mistakes deep tech founders make at seed stage don't show up until Series A, when they're nearly impossible to fix.
W. OseiThe Data Package Your Potential Acquirer Requested Is a Fishing Expedition
When a big company asks for your technical data package, they're not always serious buyers. Here's how to tell the difference and protect yourself.
W. OseiThe License Agreement Your University Wants You to Sign Will Strangle Your Startup
Before you sign that exclusive license from your university tech transfer office, understand exactly which clauses will make you unfundable and unsellable.
W. OseiThe Strategic Partnership MOU Your Fortune 500 Contact Sent You Is a Stall Tactic
That MOU from a big corporate partner feels like validation, but it's often a delay mechanism. Here's how to tell the difference and what to do about it.
W. OseiThe Non-Disclosure Agreement Your Potential Partner Sent You Is a Trap
That NDA from your potential industry partner looks standard. It probably isn't. Here's what deep tech founders miss before they sign.
W. OseiThe Clinical Advisor You Just Recruited Has No Idea How to Get You Paid
Your clinical advisor is brilliant and respected. But if they can't talk reimbursement codes, they may be the most expensive hire you never paid for.
W. OseiThe Prototype You Built in the Lab Is Not a Product and Never Will Be
Your lab prototype proves the science works. It proves almost nothing about whether you can build a real product. Here's what changes between bench and shelf.
W. OseiThe Term Sheet Your Lead Investor Sent You Was Written for Their Lawyer, Not You
Most deep tech founders sign term sheets they don't fully understand. Here's what the standard clauses actually mean for your startup's future.
W. OseiThe Due Diligence Data Room You Built Will Actually Kill Your Deal
Most deep tech founders build their investor data room to impress, not to close. Here's why that instinct backfires and what to do instead.
W. OseiThe Pilot Agreement That Will Trap You Inside a Single Customer Forever
That pilot deal with your first big customer feels like validation. It might actually be the contract that kills your startup's growth before it starts.
W. OseiThe Regulatory Consultant You Hired Doesn't Actually Know Your Technology
Most deep tech founders outsource regulatory strategy too early, and to the wrong people. Here's what that mistake actually costs you.
W. OseiThe Accelerator Program That Will Waste Six Months of Your Runway
Not every accelerator is built for deep tech founders. Here's how to tell which ones will drain your runway instead of building your company.
W. OseiWhy Your Co-Founder Agreement Will Destroy Your Cap Table Before You Raise a Dollar
Most deep tech co-founder agreements are written for friendship, not survival. Here's what goes wrong, and what to fix before investors see your cap table.
W. OseiWhy Your First Licensing Deal Will Cost You More Than You Made
Licensing your deep tech looks like free money, until the audits, sublicensing traps, and milestone clawbacks hit. Here's what to watch.
W. OseiThe Letter of Intent Your First Customer Gave You Means Absolutely Nothing
A customer LOI feels like validation, but it's not a contract, not revenue, and not proof of market fit. Here's what it actually is.
W. OseiThe IP Assignment Agreement You Didn't Read Will End Your Startup
Before you raise a dollar or sign a co-founder, understand who actually owns your invention, because your university might.
W. OseiThe SBIR Trap: Why Government Grant Money Feels Like Traction But Isn't
SBIR grants fund your science, not your startup. Here's why mistaking one for the other is the most common, and costly, mistake in deep tech.
W. OseiWhy Your Grant-Funded Proof of Concept Is Lying to You
Grant funding lets you control every variable. That's exactly why your proof-of-concept data may be telling you a story that doesn't survive first contact with a real market.
W. OseiHow to Pitch Deep Tech to Non-Technical Investors Without Losing Your Soul
Technical founders often tank investor pitches by over-explaining the science. Here's how to translate your research into language that closes rounds.
W. OseiWhy Your First FDA Meeting Will Feel Like Academic Hazing
What biotech founders really face in their first FDA pre-submission meeting and how to survive the regulatory reality check.
W. OseiWhy Your First Manufacturing Partner Will Ghost You (And How to Prevent It)
Technical founders face brutal reality when manufacturers suddenly stop responding, here's why it happens and how to avoid it.
W. OseiWhy Your Scientific Advisory Board Will Sabotage Your Startup
How prestigious scientific advisors can kill your deep tech startup with academic thinking and misaligned incentives.
W. OseiYour Lab Equipment Budget vs. Real-World Manufacturing Costs: A Reality Check
Why that $500K mass spectrometer in your lab doesn't translate to viable manufacturing economics for your startup.
W. OseiWhen Your University Tech Transfer Office Becomes Your First Real Enemy
Why university tech transfer offices often sabotage startup dreams and how to fight back with strategy.
W. OseiWhy Your First Customer Development Interview Will Go Horribly Wrong
Common mistakes technical founders make in early customer interviews and how to avoid turning conversations into product pitches.
W. OseiYour PhD Prepared You for Exactly Nothing About Starting a Company
Graduate school trains you to be a researcher. It does not train you to sell, hire, manage cash flow, or make decisions with incomplete data on a deadline.
W. OseiThe Three Pivot Points Every Technical Founder Hits
Technical founders from academia reliably hit three inflection points where the company almost dies. Recognizing them early does not make them painless, but it makes them survivable.
W. Osei